Recent Finacing
Recent Raise
Intersect ENT develops and manufactures bioabsorbable, steroid-releasing sinus stents (Propel, Propel Mini) implanted by ENTs after sinus surgery to maintain ostial patency and deliver local steroids.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors